Skripsi

ANALISIS SUMBER DAN PENGGUNAAN DANA PADA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA.

---

Penilaian

---

The purpose of this study is to find out how the sources and uses of funds in pharmaceutical companies listed on the Indonesian Stock Exchange. The population in this study were 11 pharmaceutical companies on the Indonesia Stock Exchange using a purposive sampling technique. The data analysis technique used is descriptive analysis. The results of this study indicate that during the periods 2018-2019, 2019-2020, and 2020-2021 there were five pharmaceutical companies whose sources and uses of funds were appropriate, including PT. Indofarma Tbk, PT. Pyridam Farma, PT. Organon, PT. Tempo Scan, and PT. Sido Muncul. Meanwhile, companies whose sources and uses of funds were inappropriate in the 2018-2019, 2019-2020 and 2020-2021 periods, namely PT. Kimia Farma. PT. Darya Varia for the 2018-2019 and 2020-2021 periods the sources and uses of funds are appropriate, while the 2019-2020 period is not yet appropriate. Sources and use of PT. Kalbe Farma's 2018-2019 period is not yet appropriate, while the 2019-2020 and 2020-2021 periods are appropriate. Sources and uses of PT. Phapros and PT. Merck for the 2018-2019 and 2019-2020 periods is not yet appropriate and the 2020-2021 period is appropriate.

---

Availability

Inventory Code	Barcode	Call Number	Location	Status
2307002156	T107895	T1078952023	Central Library (Referens)	Available

Detail Information

Series Title

-

Call Number

T1078952023

Publisher

Indralaya : Prodi Manajemen, Fakultas Ekonomi Universitas Srwijaya., 2023

Collation

xviii, 168 hlm.; Ilus.; 29 cm

Language

Indonesia

ISBN/ISSN

-

Classification

658.150 7

Content Type

Text

Media Type

unmediated

Carrier Type

-

Edition

-

Subject(s)

Prodi Manajemen, Manajemen Keuangan

Specific Detail Info

-

Statement of Responsibility

MURZ

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment